Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
6,144
datasets available to search
ShareScore release 0.9.0
Dataset results
6,144 results for “cancer treatment”
Pre-Treatment Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Occult Cervical Metastasis in Clinically Negative Neck Supraglottic and Glottic Cancer
<p>I uploaded the dataset of the patient enrolled in the manuscript: Salzano, Giovanni, Francesco Perri, Fabio Maglitto, Giulia Togo, Gianluca R. De Fazio, Michela Apolito, Federica Calabria, Claudia Laface, Luigi A. Vaira, Umberto Committeri, Mario Balia, Ettore Pavone, Corrado Aversa, Francesco A. Salzano, Vincenzo Abbate, Alessandro Ottaiano, Marco Cascella, Mariachiara Santorsola, Roberta Fusco, Luigi Califano, and Franco Ionna. 2021. "Pre-Treatment Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Occult Cervical Metastasis in Clinically Negative Neck Supraglottic and Glottic Cancer" <em>Journal of Personalized Medicine</em> 11, no. 12: 1252. https://doi.org/10.3390/jpm11121252</p>
Supplemental files for Clinical outcome after endovascular treatment in patients with active cancer and ischemic stroke: a MR CLEAN Registry substudy
<p>Supplemental files for Clinical outcome after endovascular treatment in patients with active cancer and ischemic stroke: a MR CLEAN Registry substudy</p>
Supplementary videos for Special issue_Cancers_A New Era in Treatment of Early-stage NSCLC_Takuya Watanabe
<p>Dear Editorial Office</p> <p>Please extrapolate to the manuscript as supplementary videos (Supplementary Video1-5). Thank you very much.</p> <p> </p> <p>Takuya Watanabe</p>
Mouse RNASeq data for "The tumor microbiome reacts to hypoxia and can influence response to radiation treatment in colorectal cancer", part 1
Open the record for dataset details and reuse information.
Mouse RNASeq data for "The tumor microbiome reacts to hypoxia and can influence response to radiation treatment in colorectal cancer", part 2
Open the record for dataset details and reuse information.
Accuracy of pre-treatment ultrasonography assessment of intra-abdominal spread in epithelial ovarian cancer: a prospective study
<p>Supplementary videos to article: Accuracy of pre-treatment ultrasonography assessment of intra-abdominal spread in epithelial ovarian cancer: a prospective study.</p>
Impact of Epstein Barr Virus Infection on Treatment Opportunities in Patients with Nasopharyngeal Cancer
<p>I upload the images of the manuscript "Impact of Epstein Barr Virus Infection on Treatment Opportunities in Patients with Nasopharyngeal Cancer"</p>
Phototoxicity and Cell Passage Affect Intracellular Reactive Oxygen Species Levels and Sensitivity Towards Non-Thermal Plasma Treatment in Fluorescently-Labeled Cancer Cells
<p>Raw data for the manuscript "Phototoxicity and Cell Passage Affect Intracellular Reactive Oxygen Species Levels and Sensitivity Towards Non-Thermal Plasma Treatment in Fluorescently-Labeled Cancer Cells".</p>
Fig. 1 in An overview on the role of plant-derived tannins for the treatment of lung cancer
Fig. 1. Molecular targets modulated by tannins in lung cancer. Tannins Abbreviations: CASU - casuarinin; EGCG - epigallocatechin-3-gallate; FPTF - fructus phyllanthi tannin fraction; GA – gallic acid; GERA - geraniin; GRA – granatin A; GRB – granatin B; GSPs - grape seed proanthocyanidins; GSPC - grape seed procyanidins; OEB - oenothein B; PAC – proanthocyanidin rich cranberry fraction; PARE – procyanidin rich extract from sorghum bran; PBOG - prodelphinidin B-2 3′-Ogallate; PCC – procyanidins from cinnamomi cortex; PCCC – procyanidin C1 from cinnamomi cortex; PRFR – proanthocyanidin rich fraction from red rice; TA - tannic acid; TT – total tannins. Abbreviations for molecules: AP-1 - Activator protein 1; Apaf-1 - Apoptotic protease activating factor 1; BAX - BCL2 Associated X; BCL2 - Bcell lymphoma 2; BCL-XL - B-cell lymphoma-extra large; CD31 - cluster of differentiation 31; CDK - cyclin dependent kinase; CDKN1A - cyclin-dependent kinase inhibitor; c-FLIP - FLICE-like inhibitory protein; Cip1/p21 - cyclin-dependent kinase inhibitor 1; COX-2 – cyclooxygenase-2; Cyt C - cytochrome C; E-Cad – E-cadherin; EMT – epithelial-to-mesenchymal transition; Fas - apoptosis antigen 1; FasL - Fas ligand; FN - fibronectin; GR – glutathione reductase; GSH – reduced glutathione; GST - glutathione S-transferase; 15-HETE - 15-hydroxyeicosatetraenoic acid; IGFBP-3 - insulin like factor binding protein 3; IGF-2R - insulin-like growth factor 2 receptor; Kip1/p27 - cyclin-dependent kinase inhibitor 1B; MAPK - mitogen-activated protein kinase; MDM2 - mouse double minute 2 homolog; mFasL - membrane-bound FasL; miR – microRNA; NANOG - transcriptional factor; N-cad - N-cadherin; NOX - NADPH oxidase; NF-kB - nuclear factor kappa-light-chainenhancer of activated B cells; NRF2 - nuclear factor erythroid 2 (NFE2)-related factor 2; NQO1 - NAD(P)H:quinone oxidoreductase; OCT-4 - octamer-binding transcription factor 4; PARP - poly-ADP ribose polymerase; PCNA - proliferating cell nuclear antigen; PGE2 - prostaglandin E2; 6-keto-PGF1α - 6-keto-prostaglandin F1α; PTEN - phosphatase and tensin homolog; PTGIS - prostacyclin synthase; pMDM2 – phospho mouse double minute 2 homolog; pAKT – phosphorylated protein kinase B; pERK1/2 – phosphorylated extracellular signal-regulated kinase 1/2; pJNK1/2 – phosphorylated c-Jun N-terminal kinase 1/2; pNF-kB - phosphorylated nuclear factor kappa-light-chain-enhancer of activated B cells; pPI3K – phosphorylated phosphatidylinositol 3-kinase; α-SMA – alpha-smooth muscle actin; pSmad2 – phosphorylated SMAD family member 2; pSmad3 – phosphorylated SMAD family member 3; p21/WAF1 - cyclin-dependent kinase inhibitor 1; p22phox - human neutrophil cytochrome b light chain; p47phox – neutrophil cytosol factor 1; pp38 – phosphorylated p38; Rb - retinoblastoma protein; sFasL - soluble FasL; Smac/ DIABLO - Second mitochondria-derived activator of caspase/direct inhibitor of apoptosis-binding protein with low pI; SNAIL1 - Zinc finger protein SNAI1; SOX2 - SRY (sex determining region Y)-box 2; pEGFR – phosphorylated epidermal growth factor receptor; TGF-βR1 - transforming growth factor beta receptor; UGT - uridine diphosphate glucuronosyl transferase; VIM - vimentin; VEGF - vascular endothelial growth factor; XIAP - X-linked inhibitor of apoptosis protein; ZO1 - Zonula occludens1. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
Fig. 2 in An overview on the role of plant-derived tannins for the treatment of lung cancer
Fig. 2. Schematic representation of the mechanism of action of tannins as apoptosis inducers, by targeting multiple cellular signal transduction pathways involved in cancer. Abbreviations: AA - arachidonic acid; Akt - protein kinase B; Axl - AXL receptor tyrosine kinase; BAX - BCL2 Associated X; BCL2 - B-cell lymphoma 2; BCL-XL - B-cell lymphoma-extra large; cAMP - adenosine 3′,5′-cyclic monophosphate; CASU - casuarinin; COX2 – cyclooxygenase 2; Cyt C - cytochrome c; EGCG - epigallocatechin-3-gallate; EGFR - epidermal growth factor receptor; EP receptor - E prostanoid receptor; FADD - Fas-associated protein with death domain; Fas - apoptosis antigen 1; FasL - Fas ligand; FPTF - fructus phyllanthi tannin fraction; GA – gallic acid; GERA - geraniin; GRA - granatin A; GRB - granatin B; GSP - grape seed proanthocyanidins; GSPC - grape seed procyanidins; 15-HETE - 15-Hydroxyeicosatetraenoic acid; IP receptor - prostacyclin receptor; 15-LOX-2 - 15-lipoxygenase-2; MAPK - mitogen-activated protein kinase; MMP - mitochondrial membrane potential; OEB - oenothein B; PAC – proanthocyandin-rich cranberry fraction; PARP - poly-ADP ribose polymerase; PBOG - prodelphinidin B-2 3′-O-gallate; PGE - prostaglandin E2; PGI - prostaglandin I2; PKA - protein kinase A; PI3K - 2 2 phosphatidylinositol 3-kinase; PLA2 - phospholipase A2; PTGIS - prostacyclin synthase; ROS - reactive oxygen species; TA – tannic acid; TAM receptors - receptor tyrosine kinases; Tyro3 - TYRO3 protein tyrosine kinase. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
Suubi4Cancer: Improving Access to Pediatric Cancer Services and Treatment Adherence Among Children Living With HIV/AIDS
ClinicalTrials.gov study NCT03916783. IPD Sharing: YES. Countries: 1. Publications: 1.
Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)
ClinicalTrials.gov study NCT06486441. IPD Sharing: NO. Countries: 19. Publications: 1.
Camrelizumab Combined With Albumin-bound Paclitaxel and S-1 in the Treatment of Advanced Gastric Cancer
ClinicalTrials.gov study NCT04675866. IPD Sharing: Not stated. Countries: 1. Publications: 1.
SLOG vs mFOLFIRINOX as the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT03443492. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety Evaluation of Traditional Chinese Medicine in the Treatment of Advanced Colorectal Cancer
ClinicalTrials.gov study NCT02923622. IPD Sharing: NO. Countries: 1. Publications: 1.
Impact of Sick Peer Relation on Adaptation to Disease and on Treatment of Cancer-suffering Adolescents & Young Adults
ClinicalTrials.gov study NCT03964116. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of On-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer Patients
ClinicalTrials.gov study NCT05487248. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Second Line Treatment With Nal-IRI and S1 in Pancreatic Cancer
ClinicalTrials.gov study NCT03986294. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of Eribulin in the Treatment of Advanced Breast Cancer
ClinicalTrials.gov study NCT04683445. IPD Sharing: NO. Countries: 1. Publications: 3.
HumanaH - Hu3s193 in the Treatment of Advanced Breast Cancer After Hormonal Therapy
ClinicalTrials.gov study NCT01370239. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.